visible-on: Access Campaign
MSF response on the India-EFTA free trade agreement negotiations in Liechtenstein this week
Gilead attempt to secure patent on hepatitis C drug opposed in India
MSF Responds to EMA approval of new tuberculosis drug delamanid
Global Vaccine Community Must Make Major Changes to Reach More Children
US Pressure on India Threatens Access to Medicines
Medicines Shouldn’t be a Luxury
MSF Urges Countries Not to Trade Away Health as Trans-Pacific Trade Pact Negotiations Intensify
Trans-Pacific Trade Agreement Could Block Patient Access to Affordable Generic Medicines
MSF Welcomes WHO Guidelines On TB Drug Bedaquiline, But More Work Needed